These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 27109478)
1. PPARγ suppresses the proliferation of cardiac myxoma cells through downregulation of MEF2D in a miR-122-dependent manner. Qiu Y; Yang J; Bian S; Chen G; Yu J Biochem Biophys Res Commun; 2016 Jun; 474(3):560-565. PubMed ID: 27109478 [TBL] [Abstract][Full Text] [Related]
2. miR-218 suppresses cardiac myxoma proliferation by targeting myocyte enhancer factor 2D. Cao Q; Dong P; Wang Y; Zhang J; Shi X; Wang Y Oncol Rep; 2015 May; 33(5):2606-12. PubMed ID: 25812649 [TBL] [Abstract][Full Text] [Related]
3. The involvement of myocyte enhancer factor 2D in regulating tumor biology of cardiac myxoma. Huo Y; Zhao Q; Wang C; Zhao F; Du Y; Sun W Tumour Biol; 2016 Apr; 37(4):5405-11. PubMed ID: 26563368 [TBL] [Abstract][Full Text] [Related]
4. PPARγ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo. Yuan Z; Luo G; Li X; Chen J; Wu J; Peng Y Cell Signal; 2016 Mar; 28(3):158-164. PubMed ID: 26721185 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin. Zhao YY; Zhao LN; Wang P; Miao YS; Liu YH; Wang ZH; Ma J; Li Z; Li ZQ; Xue YX J Neurosci Res; 2015 Dec; 93(12):1891-902. PubMed ID: 26356851 [TBL] [Abstract][Full Text] [Related]
6. miR-217 suppresses proliferation and promotes apoptosis in cardiac myxoma by targeting Interleukin-6. Zhang J; Wang C; Xu H Biochem Biophys Res Commun; 2017 Aug; 490(3):713-718. PubMed ID: 28642131 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study. Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201 [TBL] [Abstract][Full Text] [Related]
9. PPARγ inhibits ovarian cancer cells proliferation through upregulation of miR-125b. Luo S; Wang J; Ma Y; Yao Z; Pan H Biochem Biophys Res Commun; 2015 Jun; 462(2):85-90. PubMed ID: 25944662 [TBL] [Abstract][Full Text] [Related]
10. Peroxisome Proliferator-Activated Receptor γ and microRNA 98 in Hypoxia-Induced Endothelin-1 Signaling. Kang BY; Park KK; Kleinhenz JM; Murphy TC; Green DE; Bijli KM; Yeligar SM; Carthan KA; Searles CD; Sutliff RL; Hart CM Am J Respir Cell Mol Biol; 2016 Jan; 54(1):136-46. PubMed ID: 26098770 [TBL] [Abstract][Full Text] [Related]
11. miR-218 suppressed the growth of lung carcinoma by reducing MEF2D expression. Song L; Li D; Zhao Y; Gu Y; Zhao D; Li X; Bai X; Sun Y; Zhang X; Sun H; Wang Y; Peng L Tumour Biol; 2016 Mar; 37(3):2891-900. PubMed ID: 26409449 [TBL] [Abstract][Full Text] [Related]
12. Activation of PPARγ inhibits pro-inflammatory cytokines production by upregulation of miR-124 in vitro and in vivo. Wang D; Shi L; Xin W; Xu J; Xu J; Li Q; Xu Z; Wang J; Wang G; Yao W; He B; Yang Y; Hu M Biochem Biophys Res Commun; 2017 May; 486(3):726-731. PubMed ID: 28342874 [TBL] [Abstract][Full Text] [Related]
13. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. Wang W; Chen LC; Qian JY; Zhang Q Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9829-9839. PubMed ID: 31799650 [TBL] [Abstract][Full Text] [Related]
14. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19. Xu K; Zhao YC Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410 [TBL] [Abstract][Full Text] [Related]
15. Negative regulation of NOD1 mediated angiogenesis by PPARγ-regulated miR-125a. Kang H; Park Y; Lee A; Seo H; Kim MJ; Choi J; Jo HN; Jeong HN; Cho JG; Chang W; Lee MS; Jeon R; Kim J Biochem Biophys Res Commun; 2017 Jan; 482(1):28-34. PubMed ID: 27836539 [TBL] [Abstract][Full Text] [Related]
16. PPARγ-mediated G-protein coupled receptor 120 signaling pathway promotes transcriptional activation of miR-143 in adipocytes. Bae IS; Park PJ; Lee JH; Cho EG; Lee TR; Kim SH Gene; 2017 Aug; 626():64-69. PubMed ID: 28495174 [TBL] [Abstract][Full Text] [Related]
17. miR-103 promotes 3T3-L1 cell adipogenesis through AKT/mTOR signal pathway with its target being MEF2D. Li M; Liu Z; Zhang Z; Liu G; Sun S; Sun C Biol Chem; 2015 Mar; 396(3):235-44. PubMed ID: 25400071 [TBL] [Abstract][Full Text] [Related]
18. Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells. Zhao Y; Li Y; Ma Y; Wang S; Cheng J; Yang T; Sun Z; Kuang Y; Huang H; Fan K; Gu J Tumour Biol; 2016 Jan; 37(1):601-10. PubMed ID: 26234765 [TBL] [Abstract][Full Text] [Related]
19. Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death. Yang S; Gao L; Lu F; Wang B; Gao F; Zhu G; Cai Z; Lai J; Yang Q J Neuroinflammation; 2015 Feb; 12():33. PubMed ID: 25890150 [TBL] [Abstract][Full Text] [Related]
20. miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages. Zhao R; Feng J; He G Biochem Biophys Res Commun; 2014 Jun; 448(3):329-34. PubMed ID: 24751522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]